Skip to content

Randomized, Double-blind, Placebo-controlled, Proof-of-concept Phase II Trial Investigating the Effect of Valproic Acid in Women with Adenomyosis.

Status
Not yet recruiting
Phases
Phase 2
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-523076-23-00
Enrollment
60
Registered
2026-04-03
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenomyosis

Brief summary

Pre−post absolute change between baseline and final value after 29 days treatment in AAPP, Final value at the end of 29 days of treatment in the amount of analgesic rescue medication taken (ibuprofen 400 mg tablets)

Detailed description

Pre−post absolute change of each pain type associated with adenomyosis (non-menstrual pelvic pain, dysmenorrhea, dyspareunia) as documented on a VAS (in units) at each visit, Clinical Global Impressions (CGI) scale after EoT on Day 30 (+4 days) visit), Patient Global Impression of Change (PGIC) scale after EoT on Day 30 (+4 days) visit), Pre−post absolute change in the lesion(s) size after EoT on Day 30 (+4 days) visit), Pregnancy rate after the first in vitro fertilization cycle performed after a wash-out period of at least 30 days after the end of treatment

Interventions

DRUGМИГ-400 400 mg филмирани таблетки
DRUGНАТРИЕВ ХЛОРИД СОФАРМА 9 mg/ml инжекционен разтвор
DRUGKонвулекс хроно 500 mg таблетки с удължено освобождаване
DRUGКонвулекс 100 mg/ml инжекционен разтвор/инфузионен разтвор
DRUGComparator 2: hard gelatine capsules (no active compounds)

Sponsors

CCDRD Cooperative Clinical Drug Research and Development AG, Nadezhda Reproductive Science OOD
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Design outcomes

Primary

MeasureTime frame
Pre−post absolute change between baseline and final value after 29 days treatment in AAPP, Final value at the end of 29 days of treatment in the amount of analgesic rescue medication taken (ibuprofen 400 mg tablets)

Secondary

MeasureTime frame
Pre−post absolute change of each pain type associated with adenomyosis (non-menstrual pelvic pain, dysmenorrhea, dyspareunia) as documented on a VAS (in units) at each visit, Clinical Global Impressions (CGI) scale after EoT on Day 30 (+4 days) visit), Patient Global Impression of Change (PGIC) scale after EoT on Day 30 (+4 days) visit), Pre−post absolute change in the lesion(s) size after EoT on Day 30 (+4 days) visit), Pregnancy rate after the first in vitro fertilization cycle performed after a wash-out period of at least 30 days after the end of treatment

Outcome results

None listed

Source: EU CTIS · Data processed: Apr 4, 2026